These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 65433)

  • 1. Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.
    Baltimore RS; Kasper DL; Baker CJ; Goroff DK
    J Immunol; 1977 Feb; 118(2):673-8. PubMed ID: 65433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.
    Hemming VG; Hall RT; Rhodes PG; Shigeoka AO; Hill HR
    J Clin Invest; 1976 Dec; 58(6):1379-87. PubMed ID: 62761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic variability of X-protein expression by mastitis-causing Streptococcus agalactiae of serotype NT/X and opsonic activities of specific antibodies.
    Rainard P; Sarradin P; Poutrel B
    Microb Pathog; 1994 May; 16(5):359-72. PubMed ID: 7815919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides.
    Schifferle RE; Jennings HJ; Wessels MR; Katzenellenbogen E; Roy R; Kasper DL
    J Immunol; 1985 Dec; 135(6):4164-70. PubMed ID: 3934276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of Pasteurella multocida to rabbit neutrophil phagocytosis and killing.
    Rush HG; Glorioso JC; DaRif CA; Olson LC
    Am J Vet Res; 1981 Oct; 42(10):1760-8. PubMed ID: 7325438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
    Baker CJ; Edwards MS; Webb BJ; Kasper DL
    J Clin Invest; 1982 Feb; 69(2):394-404. PubMed ID: 7035495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actinobacillus (Haemophilus) pleuropneumoniae serotype-8 isolates and their antigenic relationships with other A pleuropneumoniae serotypes.
    Mittal KR; Higgins R; Larivière S
    Am J Vet Res; 1989 Feb; 50(2):259-62. PubMed ID: 2470278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity to the group B streptococci: interaction of serum and macrophages with types Ia, Ib, and Ic.
    Anthony BF
    J Exp Med; 1976 May; 143(5):1186-98. PubMed ID: 772153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple polysaccharide antigens of group B streptococcus, type Ia: emphasis on a sialic acid type-specific polysaccharide.
    Kane JA; Karakawa WW
    J Immunol; 1977 Jun; 118(6):2155-60. PubMed ID: 68081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines.
    Brigtsen AK; Kasper DL; Baker CJ; Jennings HJ; Guttormsen HK
    J Infect Dis; 2002 May; 185(9):1277-84. PubMed ID: 12001045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein.
    Beachey EH; Seyer JM
    J Immunol; 1986 Mar; 136(6):2287-92. PubMed ID: 2419429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.
    Fujieda M; Aoyagi Y; Matsubara K; Takeuchi Y; Fujimaki W; Matsushita M; Bohnsack JF; Takahashi S
    Infect Immun; 2012 Jun; 80(6):2053-60. PubMed ID: 22451515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
    Bessen D; Fischetti VA
    J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological differentiation of strains of group B streptococci by the soft-agar technique.
    Ichiman Y; Kono E; Kushiro H; Ito S; Yoshida K
    Zentralbl Bakteriol A; 1981; 249(2):184-9. PubMed ID: 7023124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characteristics of antibodies induced by Arg-gingipain (HRgpA) and Lys-gingipain (Kgp) from Porphyromonas gingivalis.
    Nakagawa T; Sims T; Fan Q; Potempa J; Travis J; Houston L; Page RC
    Oral Microbiol Immunol; 2001 Aug; 16(4):202-11. PubMed ID: 11442844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart-reactive antibodies in rabbit anti-Streptococcus mutans sera fail to cross-react with Streptococcus mutans.
    Swartzwelder FJ; Barua PK; Albini B; Stinson MW
    J Immunol; 1988 Feb; 140(3):954-61. PubMed ID: 3276785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological markers of the R4 protein of Streptococcus agalactiae.
    Maeland JA; Bevanger L; Lyng RV
    Clin Diagn Lab Immunol; 2005 Nov; 12(11):1305-10. PubMed ID: 16275945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and serological relationships among different antibodies from the same rabbit antiserum. II. The idiotypes of ten antibody components from an anti-streptococcal serum.
    Aasted B; Kindt TJ
    Eur J Immunol; 1976 Oct; 6(10):727-32. PubMed ID: 65143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and physico-chemical characterisation of a candidate conjugate vaccine against group B streptococcus serotypes Ia, Ib and III.
    Lancaster L; Saydam M; Markey K; Ho MM; Mawas F
    Vaccine; 2011 Apr; 29(17):3213-21. PubMed ID: 21356338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse protection test for group B Streptococcus type III.
    Baltimore RS; Kasper DL; Vecchitto J
    J Infect Dis; 1979 Jul; 140(1):81-8. PubMed ID: 88492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.